Literature DB >> 27571935

MicroRNA-137 suppresses tongue squamous carcinoma cell proliferation, migration and invasion.

Lanying Sun1,2, Jin Liang1, Qibao Wang3, Zhaoyuan Li2, Yi Du3, Xin Xu4.   

Abstract

OBJECTIVES: Tongue squamous cell carcinoma (TSCC) is the most frequent type of oral malignancy. Increasing evidence has shown that miRNAs play key roles in many biological processes such as cell development, invasion, proliferation, differentiation, metabolism, apoptosis and migration.
MATERIALS AND METHODS: qRT-PCR analysis was performed to measure miR-137 expression. CCK-8 analysis, cell colony formation, wound-healing analysis and invasion were performed to detect resultant cell functions. The direct target of miR-137 was labelled and measured by luciferase assay and Western blotting.
RESULTS: We demonstrated that expression of miR-137 was downregulated in TSCC tissues compared to matched normal ones. miR-137 expression was downregulated in TSCC lines (SCC4, SCC1, UM1 and Cal27) compared to the immortalized NOK16B cell line and normal oral keratinocytes in culture (NHOK). In addition, we have shown that miR-137 expression was epigenetically regulated in TSCCs. Overexpression of miR-137 suppressed TSCC proliferation and colony formation. Ectopic expression of miR-137 promoted expression of the epithelial biomarker, E-cadherin, and inhibited the mesenchymal biomarker, N-cadherin, as well as vimentin and Snail expression, indicating that miR-137 suppressed TSCC epithelial-mesenchymal transition (EMT). We also showed that ectopic expression of miR-137 inhibited TSCC invasion and migration. In addition, we identified SP1 as a direct target gene of miR-137 in SCC1 cells. SP1 overexpression rescued inhibitory effects exerted by miR-137 on cell proliferation and EMT.
CONCLUSIONS: These results indicate that miR-137 acted as a tumour suppressor in TSCC by targeting SP1.
© 2016 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27571935      PMCID: PMC6495205          DOI: 10.1111/cpr.12287

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  48 in total

1.  MicroRNA-195 inhibits non-small cell lung cancer cell proliferation, migration and invasion by targeting MYB.

Authors:  Zhou Yongchun; Tian Linwei; Wang Xicai; Ye Lianhua; Zhao Guangqiang; Yu Ming; Li Guanjian; Lei Yujie; Huang Yunchao
Journal:  Cancer Lett       Date:  2014-01-29       Impact factor: 8.679

2.  Expression of microRNA-195 is transactivated by Sp1 but inhibited by histone deacetylase 3 in hepatocellular carcinoma cells.

Authors:  Na Zhao; Siwen Li; Ruizhi Wang; Manhuan Xiao; Yu Meng; Chunxian Zeng; Jian-Hong Fang; Jine Yang; Shi-Mei Zhuang
Journal:  Biochim Biophys Acta       Date:  2016-05-11

3.  MicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancer.

Authors:  Biqiang Zheng; Linhui Liang; Chunmeng Wang; Shenglin Huang; Xi Cao; Ruopeng Zha; Li Liu; Deshui Jia; Qi Tian; Jianghong Wu; Yanwei Ye; Qifeng Wang; Ziwen Long; Ye Zhou; Chunyan Du; Xianghuo He; Yingqiang Shi
Journal:  Clin Cancer Res       Date:  2011-10-12       Impact factor: 12.531

4.  MicroRNA-193a-3p and -5p suppress the metastasis of human non-small-cell lung cancer by downregulating the ERBB4/PIK3R3/mTOR/S6K2 signaling pathway.

Authors:  T Yu; J Li; M Yan; L Liu; H Lin; F Zhao; L Sun; Y Zhang; Y Cui; F Zhang; J Li; X He; M Yao
Journal:  Oncogene       Date:  2014-01-27       Impact factor: 9.867

5.  The role of prophylactic neck dissection and tumor thickness evaluation for patients with cN0 tongue squamous cell carcinoma.

Authors:  Nayuta Tsushima; Tomohiro Sakashita; Akihiro Homma; Hiromitsu Hatakeyama; Satoshi Kano; Takatsugu Mizumachi; Tomohiko Kakizaki; Takayoshi Suzuki; Satoshi Fukuda
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-05-05       Impact factor: 2.503

6.  miR-137 acts as a tumor suppressor in astrocytoma by targeting RASGRF1.

Authors:  Danni Deng; Lian Xue; Naiyuan Shao; Hongtao Qu; Qiang Wang; Suinuan Wang; Xiwei Xia; Yilin Yang; Feng Zhi
Journal:  Tumour Biol       Date:  2015-10-06

7.  Squamous cell carcinoma of oral tongue in young patients - A 10 years tertiary care experience.

Authors:  Mohammad Adeel; Anwar Suhail
Journal:  J Pak Med Assoc       Date:  2016-02       Impact factor: 0.781

8.  Inactivation of PI3-K/Akt and reduction of SP1 and p65 expression increase the effect of solamargine on suppressing EP4 expression in human lung cancer cells.

Authors:  YuQing Chen; Qing Tang; JingJing Wu; Fang Zheng; LiJun Yang; Swei Sunny Hann
Journal:  J Exp Clin Cancer Res       Date:  2015-12-21

9.  MicroRNA-137 inhibits tumor growth and sensitizes chemosensitivity to paclitaxel and cisplatin in lung cancer.

Authors:  Hua Shen; Lin Wang; Xin Ge; Cheng-Fei Jiang; Zhu-Mei Shi; Dong-Mei Li; Wei-Tao Liu; Xiaobo Yu; Yong-Qian Shu
Journal:  Oncotarget       Date:  2016-04-12

10.  miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells.

Authors:  Joachim Silber; Daniel A Lim; Claudia Petritsch; Anders I Persson; Alika K Maunakea; Mamie Yu; Scott R Vandenberg; David G Ginzinger; C David James; Joseph F Costello; Gabriele Bergers; William A Weiss; Arturo Alvarez-Buylla; J Graeme Hodgson
Journal:  BMC Med       Date:  2008-06-24       Impact factor: 8.775

View more
  24 in total

1.  MiR-200a inhibits cell proliferation and EMT by down-regulating the ASPH expression levels and affecting ERK and PI3K/Akt pathways in human hepatoma cells.

Authors:  Wei-Feng Yao; Jun-Wei Liu; Dong-Sheng Huang
Journal:  Am J Transl Res       Date:  2018-04-15       Impact factor: 4.060

2.  MicroRNA-429 inhibits gastric cancer migration and invasion through the downregulation of specificity protein 1.

Authors:  Jingbin Ni; Yisha Yang; Di Liu; Hui Sun; Shimao Jin; Jingying Li
Journal:  Oncol Lett       Date:  2017-03-17       Impact factor: 2.967

3.  Establishment of an miR-137-knockout cell model using CRISPR/Cas9 genome editing.

Authors:  Wei Chen; Qi Li; Jingjie Du; Xiaodi Li; Songshan Jiang; Yuanli He
Journal:  Oncol Lett       Date:  2018-07-06       Impact factor: 2.967

4.  Correlation between tissue expression of microRNA-137 and CD8 in oral lichen planus.

Authors:  Sana Maher Hasan Aghbari; Abdelrahman Ibrahim Abushouk; Olfat Gamil Shakir; Shaimaa Omar Zayed; Attia Attia
Journal:  Clin Oral Investig       Date:  2017-10-15       Impact factor: 3.573

5.  Long non-coding RNA CASC15 promotes tongue squamous carcinoma progression through targeting miR-33a-5p.

Authors:  Zhibin Zuo; Long Ma; Zuode Gong; Lande Xue; Qibao Wang
Journal:  Environ Sci Pollut Res Int       Date:  2018-05-26       Impact factor: 4.223

6.  MiR-940 inhibits migration and invasion of tongue squamous cell carcinoma via regulatingCXCR2/NF-κB system-mediated epithelial-mesenchymal transition.

Authors:  Tie Ma; Zhiguo Zhao; Zhiming Wang; Chuanning Wang; Liping Zhang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-06-18       Impact factor: 3.000

7.  Effect of chromodomain helicase/ATPase DNA binding protein 1-like gene on the invasion and metastasis of tongue squamous cell carcinoma CAL27 cells.

Authors:  Kai-Li Hu; Xin Fan; Wen-Ting Hu; Hong-Li Li; Qing-Hua Tang; Xue-Hui Sun
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2021-02-01

8.  lncRNA RPSAP52 induced the development of tongue squamous cell carcinomas via miR-423-5p/MYBL2.

Authors:  Xiaozhen Wu; Zuode Gong; Long Ma; Qibao Wang
Journal:  J Cell Mol Med       Date:  2021-03-30       Impact factor: 5.310

9.  SNHG1/miR-194-5p/MTFR1 Axis Promotes TGFβ1-Induced EMT, Migration and Invasion of Tongue Squamous Cell Carcinoma Cells.

Authors:  Yonglu Jia; Xiaojuan Chen; Dayong Zhao; Sancheng Ma
Journal:  Mol Biotechnol       Date:  2022-02-02       Impact factor: 2.695

10.  SNHG17 enhances the malignant characteristics of tongue squamous cell carcinoma by acting as a competing endogenous RNA on microRNA-876 and thereby increasing specificity protein 1 expression.

Authors:  Xiaoming Liu; Baorong Zhang; Yue Jia; Ming Fu
Journal:  Cell Cycle       Date:  2020-02-23       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.